Health Risk Assessment of Atmospheric Fine Particulate Matter (PM2.5): Sampling, Analysis, and Evalu

Atmospheric fine particulate matter (PM2.5) is one of the most significant airborne pollutants affecting human health, capable of penetrating deep into the alveolar region and entering the bloodstream. A comprehensive PM2.5 health risk assessment combines gravimetric and speciation analysis with exposure modeling to quantify non-carcinogenic and carcinogenic risks for exposed populations. This article outlines the sampling procedures, analytical parameters, evaluation methods, and typical applications of professional PM2.5 health risk assessment services provided by accredited third-party laboratories.

Technical Overview

Fine particulate matter, designated PM2.5, refers to particles with an aerodynamic equivalent diameter of 2.5 micrometers or less suspended in ambient air. Due to their extremely small size, these particles bypass the natural filtration mechanisms of the upper respiratory tract, deposit in the gas-exchange regions of the lungs, and can translocate into the circulatory system. The health hazard of PM2.5 is determined not only by its mass concentration but also by its chemical composition, which typically includes water-soluble ions, carbonaceous species, heavy metals, and polycyclic aromatic hydrocarbons (PAHs) adsorbed onto particle surfaces.

A health risk assessment of atmospheric fine particulate matter follows the internationally recognized four-step framework: hazard identification, dose-response assessment, exposure assessment, and risk characterization. In this framework, the measured concentrations of toxic components such as arsenic, cadmium, chromium(VI), nickel, lead, manganese, and benzo[a]pyrene are combined with population exposure parameters to calculate quantitative risk indicators, including the hazard quotient (HQ), hazard index (HI) for non-carcinogenic effects, and incremental lifetime cancer risk (ILCR) for carcinogenic effects. The results are benchmarked against guidelines published by the World Health Organization (WHO) and national ambient air quality standards such as GB 3095, providing a scientific basis for pollution control and public health protection.

Testing Samples

Ambient Air Samples

Samples are collected from urban background stations, residential areas, traffic corridors, and industrial zones using reference-equivalent PM2.5 samplers operating at a controlled flow rate over 24-hour or continuous multi-day cycles. Quartz fiber and Teflon filter membranes are loaded in parallel to support gravimetric, ionic, elemental, and carbonaceous analysis from a single integrated sampling campaign.

Indoor Air Samples

Indoor PM2.5 samples are collected from residences, offices, schools, hospitals, and underground parking structures to evaluate infiltration of outdoor particles and the contribution of indoor sources such as cooking, smoking, incense burning, and building materials. Indoor-outdoor concentration ratios (I/O ratios) are derived to characterize exposure microenvironments.

Occupational and Source Samples

Workplace samples from welding workshops, construction sites, mining operations, and manufacturing facilities are collected to support occupational exposure evaluation. Emission source samples, including stack gas, fugitive dust, road dust, and vehicle exhaust particulates, may also be gathered to enable source apportionment analysis through receptor modeling techniques.

Archived Filter Membranes

Previously collected filter membranes from existing air monitoring networks can be submitted for retrospective chemical speciation, allowing historical exposure reconstruction and long-term trend analysis without the need for new field campaigns.

Testing Items

The testing program for a PM2.5 health risk assessment typically covers the following parameter groups:

• Physical characteristics: PM2.5 mass concentration, particle number concentration, and particle size distribution
• Water-soluble inorganic ions: sulfate, nitrate, ammonium, chloride, potassium, sodium, calcium, and magnesium
• Carbonaceous components: organic carbon (OC), elemental carbon (EC), and the OC/EC ratio
• Heavy metals and trace elements: arsenic, cadmium, chromium, nickel, lead, manganese, mercury, antimony, selenium, vanadium, copper, zinc, and aluminum
• Polycyclic aromatic hydrocarbons (PAHs): 16 priority PAHs including benzo[a]pyrene, benzo[a]anthracene, and dibenz[a,h]anthracene
• Derived indicators: hazardous index values (HQ, HI), incremental lifetime cancer risk (ILCR), and carcinogenic equivalent concentration (BaPeq)

Testing Methods

Sampling and Mass Determination

PM2.5 is collected using impactor- or cyclone-based samplers designed in accordance with EN 12341 and GB/T series reference methods for the gravimetric measurement of PM2.5 fractions. Filter membranes are equilibrated in temperature- and humidity-controlled chambers and weighed on high-precision microbalances to determine mass concentration in accordance with the applicable national reference method for ambient air quality. Continuous monitoring instruments employing beta attenuation, oscillating microbalance, or light-scattering principles, calibrated per ISO 21501-4, are used to capture real-time concentration profiles and diurnal variation.

Chemical Speciation Analysis

• Water-soluble ions are extracted ultrasonically and quantified by ion chromatography
• Organic and elemental carbon are determined by thermal-optical transmittance or reflectance analysis
• Heavy metals are quantified by inductively coupled plasma mass spectrometry (ICP-MS) or ICP optical emission spectrometry following acid digestion, referencing test methods such as ASTM D7439, with X-ray fluorescence spectrometry used for non-destructive screening
• PAHs are extracted with organic solvents, cleaned up through solid-phase extraction, and quantified by gas chromatography-mass spectrometry (GC-MS)
• Particle size distribution is characterized using electrical mobility and aerodynamic particle sizing systems in line with ISO 15900 principles

Risk Characterization Models

Chronic daily intake (CDI) of each hazardous component is calculated from the measured concentration, inhalation rate, exposure frequency, exposure duration, body weight, and averaging time. Non-carcinogenic risk is expressed as the hazard quotient, calculated as the ratio of chronic daily intake to the reference dose or reference concentration, with the hazard index obtained by summing hazard quotients across all pathways and substances; values below 1 are generally considered acceptable. Carcinogenic risk is calculated as the product of lifetime average daily dose and the cancer slope factor for substances classified as Group 1 or Group 2A human carcinogens by the International Agency for Research on Cancer (IARC), with an acceptable risk range typically defined between 1E-06 and 1E-04. Where source attribution is required, positive matrix factorization (PMF) or chemical mass balance (CMB) receptor models are applied to the speciation dataset to identify contributions from traffic, coal combustion, biomass burning, industrial emissions, and dust.

Applications

• Urban and regional air quality management, including control strategy evaluation and attainment analysis against GB 3095 and WHO guideline values
• Environmental impact assessment and post-construction acceptance monitoring for industrial projects in the energy, metallurgy, chemical, and building materials sectors
• Public health and epidemiological studies linking PM2.5 exposure to cardiovascular, respiratory, and carcinogenic health endpoints
• Occupational health evaluation for workers exposed to welding fume, foundry dust, and combustion particulates
• Indoor air quality assessment and green building certification support for residential, educational, and healthcare facilities
• Source apportionment and accountability studies supporting emission reduction policies and heavy pollution episode response
• Litigation support, insurance claims, and community exposure dispute resolution based on defensible analytical data

FAQ

What makes PM2.5 more hazardous than larger particles?

PM2.5 penetrates beyond the bronchial tree into the alveoli, where the blood-air barrier is extremely thin, allowing soluble toxic components such as heavy metals and PAHs to enter the bloodstream. Its large specific surface area also concentrates adsorbed carcinogens and reactive organic compounds, amplifying oxidative stress and inflammatory responses.

How long does a typical sampling campaign take?

A standard campaign involves at least seven consecutive 24-hour sampling events across representative meteorological conditions, while seasonal assessments require multi-season monitoring. Chemical speciation of the collected filters is generally completed within ten to twenty working days, and the full risk assessment report follows within an additional week.

What risk levels are considered acceptable?

For non-carcinogenic effects, a hazard index below 1 indicates that adverse effects are unlikely for the exposed population. For carcinogenic effects, an incremental lifetime cancer risk below 1E-06 is generally regarded as negligible, values between 1E-06 and 1E-04 are considered tolerable, and values above 1E-04 warrant prioritized intervention.

Can the assessment identify where the particles come from?

Yes. When full chemical speciation data are available, receptor modeling using PMF or CMB techniques can quantify the percentage contributions of major sources such as vehicular exhaust, coal combustion, secondary aerosol formation, construction dust, and industrial emissions, supporting targeted emission control measures.

Which standards govern the analysis?

Sampling and gravimetric determination follow EN 12341 and applicable national reference methods; elemental analysis references ASTM D7439; particle counter calibration follows ISO 21501-4; and risk characterization adopts the exposure assessment framework established by international environmental protection agencies together with IARC carcinogen classifications and WHO air quality guidelines.